TriSalus Life Sciences, Inc. Shareholders' Equity
TriSalus Life Sciences, Inc. (TLSI) had Shareholders' Equity of $6.55 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $6.55M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $12.81M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$33.86M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$26.73M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $6.55M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $12.81M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | -$33.86M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$26.73M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$19.42M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | -$34.37M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | -$25.89M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | -$20.43M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | -$25.26M 10-Q · filed 2025-11-13 | -$24.15M 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$36.04M 10-Q · filed 2025-11-13 | -$34.92M 10-Q · filed 2024-05-15 |
| 2023-12-31 | -$27.07M 10-K · filed 2026-03-05 | -$25.94M 10-K · filed 2024-04-11 |
| 2023-09-30 | $8.29M 10-Q · filed 2024-11-14 | $8.49M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$198.42M 10-Q · filed 2024-11-14 | -$15.12M 10-Q · filed 2023-08-02 |
| 2023-03-31 | -$184.52M 10-Q · filed 2024-11-14 | -$13.85M 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$177.13M 10-K/A · filed 2025-05-30 | -$13.27M 10-K · filed 2023-03-22 |
| 2022-09-30 | -$153.93M 10-Q · filed 2023-11-14 | -$11.66M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$145.96M 10-Q · filed 2023-11-14 | -$11.54M 10-Q · filed 2022-08-10 |
| 2022-03-31 | -$137.35M 10-Q · filed 2023-11-14 | -$13.88M 10-Q · filed 2022-05-11 |
| 2021-12-31 | -$129.60M 10-K · filed 2024-04-11 | -$16.72M 10-K · filed 2022-03-03 |
| 2021-09-30 | -$19.61M 10-Q/A · filed 2021-12-13 | |
| 2021-06-30 | -$21.48M 10-Q/A · filed 2021-12-13 | $5.00M 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$21.86M 10-Q/A · filed 2021-12-13 | $5.00M 10-Q · filed 2021-06-28 |
| 2020-12-31 | -$21.48M 10-K · filed 2022-03-03 | $5.00M 10-Q · filed 2021-06-28 |
| 2020-12-22 | -$21.30M 10-K/A · filed 2021-12-13 | |
| 2020-09-10 | $0.00 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |